Brit. med. J., 1966, 1, 695-701 Cycloguanil pamoate is an antimalarial drug recently developed by Thompson et al. (1963) Cycloguanil Pamoate Cycloguanil pamoate (Camolar; CI-501) is a pamoic acid salt of dihydrotriazine suspended in a lipid vehicle. The dihydrotriazine moiety has been described as the active metabolite of proguanil by Carrington et al. (1951) , and its soluble hydrochloride salt is known to possess high suppressive activity against the blood forms of the genus Plasmodium. Animal experiments indicated that repository action was achieved against challenge with trophozoites or sporozoites of P. cynomolgi and that the duration of action was influenced by the particulate nature of the preparation ; longest protection followed dosage with coarse rather than fine particles (Thompson et al., 1963 ; Schmidt et al., 1963) .
The therapeutic and prophylactic value of cycloguanil pamoate in man has been tested against infections with P. vivax and P. falciparum. Protection was conferred for at least six months, and often for more than a year, against trophozoite and sporozoite challenges made intermittently with P. vivax, while parasitaemia patent at the time of treatment cleared within 72 hours (Coatney et al., 1963) . Alving (1963) showed that full protection was conferred against trophozoite and sporozoite challenge with proguanil-sensitive strains of P. falciparum but not to proguanil-resistant ones. Further studies by Lunn et al. (1964) have suggested that so far as P. falciparum is concerned the drug may act as a true causal prophylactic.
As is to be suspected from its similarity to proguanil, cycloguanil pamoate is antifolic and probably disrupts normal nuclear division in plasmodia by inhibiting folic-acid metabolism. At effective dosage levels in man slight temporary * From the Medical Research Council Laboratories, Gambia. reduction has been noted in haematocrit and haemoglobin values, and in erythrocyte density in some individuals.
Field Trial Objectives
The principal objectives were to determine by controlled trial: (1) the acceptability of the drug to representatives of all age groups of a rural African population; (2) the incidence and importance of side-effects, both local and systemic, that followed drug injection ; (3) the response of existing parasitaemia to therapy; and (4) the duration of subsequent protection against natural challenge.
Selection of Subjects
Kafuta, a moderately prosperous village in the Kombo East district of the Gambia, was selected as the site after preliminary survey had confirmed its suitability, and 245 suitable subjects were allocated according to randomization tables to either drug-treated or control groups. Little effort was made to balance the groups according to sex. The eventual distribution of the subjects studied was as shown in Table I . Timing of Therapy
The results of a trial of any long-acting drug are singularly apt to be influenced by season. In the Gambia transmission of malaria is frequent in the wet months July to November, and much less common in the remaining dry months. To minimize the effects of this variation in the present study three separate series were created within both the treated and the control groups. Administration was by intramuscular injection, the buttock being constantly the site of choice. Care was taken to ensure that the drug particles were in uniform suspension. As cycloguanil pamoate is heat stable, the ampoules were warmed in boiling water, thoroughly shaken, and allowed to cool to body temperature before administration.
Methods
Two days prior to injection all members of the treatment and control groups were re-examined. The height and weight of each were recorded, and distinguishing features, including state of dentition, noted. Oxyhaemoglobin values were determined from capillary blood with the M.R.C. grey-wedge photometer (Macfarlane et al., 1948 
Results

Injection Site Reaction
February Series.-The members of this series were injected in the right gluteus maximus. In the days immediately after injection drug-treated subjects frequently complained of pain at the site, and some emphasized the point by hobbling or walking with the aid of a stick. Pain seemed to be maximal on days two and three, and thereafter rapidly abated. In contrast, few members of the control group complained or showed evidence of incapacitation.
Over the first two months 12 of the 44 drug-treated subjects complained of abscess development with subsequent pointing and discharge. In all but one inspection confirmed the history and the presence of a discharging sinus was noted. These complications usually developed in the second and third weeks following injection, but in one instance occurred nine weeks after what seemed to be entirely satisfactory drug administration. In four subjects the progress of abscess formation was observed during hospitalization. Cultures made from the discharge on Seven days after injection blood films were prepared from all but one of the drug-treated individuals and from all control subjects. After standard examination of 100 oil fields of each thick film no asexual parasites were detected in any drugtreated member, but 55% of the control subjects still showed circulating asexual parasites. The drug appeared to have no immediate effect upon gametocytes and no morphological change was noted in these following therapy; gametocytaemia persisted into the second month in 16 persons; and into the third month in one.
Chemoprophylaxis After First Injection
Of the 124 drug-treated subjects 44 were dosed in February, 45 in April, and 35 in June. Members of the February and April series maintained good attendance records throughout their respective observation periods but a high proportion of the June series refused to attend for further examination from the fourth month onwards. These non-attenders were all members of one religious minority recognized as the most uncooperative and unreliable section of the Gambian population. Freedom from asexual parasitaemia for each treatment group is shown in Fig. 1 , which illustrates the percentage of each group remaining parasite-free at week one, and at the end of each month, post injection. The figure gives the results in a cumulative manner, and to simplify presentation persons not seen, but not known to have been reinfected, are classified with those known to be parasite-free. Wherever this occurs the percentage of those non-attenders is shown. (For purposes of comparison it may be stated that the incidence of asexual parasitaemia in control subjects of all series did not fall below 48% at any month following injection.) Members of the February drug-treated series enjoyed longer freedom from malaria than did persons treated in April or June. At the end of the fourth month over 90 % showed no evidence of asexual parasitaemia and the first major wave of reinfection did not occur until the fifth month. In contrast, a high incidence of breakthrough occurred in the third and fourth months both in the April and in the June series. This difference is further emphasized by the fact that about a quarter of the persons treated in February possibly lost some part of their drug inoculum through sinus formation.
Three drug-treated members of the February series and four of the April group, each with complete attendance records, were still trophozoite-free at the tenth and eighth months respectively. All but one, a boy of 7 years, were adults. It is apparent that increase in the amount of drug administered per unit of body weight was not followed by correspondingly prolonged protection. That the lowest dosage level employed produced best results is probably explained by the fact that those who received it were adults possessing substantial immunity. In estimating drug dosage no allowance was made for drug-loss in those members of the February series who developed discharging sinuses. Since duration of protection has no obvious direct correlation with drug dose per unit of body weight, its relationship to size of the drug inoculum should be considered. Fig. 2 gives the relevant details. Again it will be noted that, whereas the adtilts who received the largest inoculum did indeed experience longer protection, little difference is obvious in the three younger groups despite substantial differences in volume of drug administered; the age group 6 to 13 years in each series fared no better than the youngest group despite a threefold difference in volume of inoculum.
Of 95 persons examined in consecutive months for six months or until reinfected 12 developed sinuses. Duration of protection is contrasted in Fig. 4 Fig. 6 .
The results expressed in this figure broadly confirm those observed after the first injection. They also confirm the proneness of those aged 6 to 13 to reinfection despite relatively high drug dosage and despite substantial acquired immunity.
Of 31 individuals who showed recurrence of parasitaemia after each of two injections of the drug the second injection conferred longer protection in four, for the same period in six, and for a shorter period in 21. On average, the first injection protected into the fourth month, and the second into the third ; but it is important to note that most of the second injections were given in the period of most intense malarial transmission.
Haematological Observations
In Table IV greatly influenced individual haemoglobin levels. It will be noted that at each observation after cycloguanil injection the mean values for the three youngest age groups exceed the pre-treatment mean value. Only in the oldest age group did the post-treatment values tend to fall below pre-treatment levels, but even here the treated group maintained values superior to those of their controls. These findings indicate either that cycloguanil pamoate did not depress erythropoiesis or that its antimalarial benefit more than balanced any possible depressant effect.
Mean haematocrit values behaved in a manner similar to those for haemoglobin. The mean haemoglobin values of the same subjects, before and after a second injection of cycloguanil, are shown in Table V . The slight falls in haemoglobin concentration recorded at week one are most likely due to malaria. The absence of any subsequent mean value lower than preinjection levels again indicates that cycloguanil exerted no depressant haematological effect.
In no instance was any abnormality detected in leucocytes or erythrocytes in routine examination of thick and thin blood films. 
Teratogenic Effects
Three women were pregnant at the time of cycloguanil injection. Two progressed normally and were ultimately delivered of healthy, normal children. The third aborted two months after therapy. Two further women became pregnant post injection; both the pregnancies progressed without incidence and both have since been delivered of normal children. From date of delivery, conception in one instance appeared to have occurred around the fifth week post injection and in the other at the twelfth week.
Four vehicle-treated women were pregnant at time of injection and a further one became pregnant post injection. All have since been delivered of normal children.
The incidence of abortion in the Gambia is high, and its occurrence in one woman treated with cycloguanil pamoate is probably unlikely to have been attributable to the drug.
Discussion
Side-effects of Cycloguanil Pamoate Thompson et al. (1963) were of the opinion that systemic toxicity was unlikely to follow the repository use of the drug, since low plasma levels were attained and no appreciable drug storage occurred in tissues other than at the injection site. Schmidt et al. (1963) , however, drew attention to the potential effects of a folic-acid antagonist on undernourished communities. It is therefore of interest that in no drug-treated member of the present trial was there observed any evidence of systemic toxicity.
Of greater concern was the severity of injection-site reactions that developed early in the trial. This was unexpected and alarming, and had we been unable to modify the course of subsequent injections our interest in cycloguanil pamoate would have ceased abruptly. However, change of site to an area relatively free from fat eliminated serious reactions, and it must be emphasized that successful large-scale administration of this drug in its present form will be conditional upon the maintenance of a high standard of injection technique.
Despite the inauspicious start, the drug remained surprisingly popular among the villagers. No person refused a second injection when one was offered, and the pain and tenderness that commonly occurred in the first few days post injection were accepted with good humour.
Chemotherapeutic Results
Two-thirds of the drug-treated subjects showed asexual parasitaemia immediately before medication. By the seventh day after drug administration asexual forms had disappeared in all instances. Since the criterion of change was based solely on the study of 100 oil fields of a thick film, caution should be exercised in the interpretation of results. Nevertheless, the uniform response of asexual parasitaemia to both first and second injections indicates the cycloguanil pamoate is a powerful schizonticide and that the prevalent plasmodial species were susceptible to the drug at the beginning of the trial and remained so throughout. Argyll, Dunbarton, Lanark, and Renfrew. This is a compact region and forms, surgically speaking, an isolated community. The hospitals in the area handle virtually all the emergencies occurring within the region and very few outside it. The population, which exceeds two million, is mainly industrial, being concentrated around Glasgow and Clydeside. The rural population, which is small, is located mainly in the highland county of Argyll.
The features of a perforated peptic ulcer are usually so dramatic that it was felt that few patients would fail to reach hospital. The study was therefore confined to a search of hospital case-records, operation log-books, and post-mortem records. Only those cases in which the perforation was confirmed, either at operation or at necropsy, were included in the survey. The so-called " leaking ulcers " recovering without operation were excluded from the survey, as most clinicians agree that such a diagnosis is difficult to establish with certainty.
All the hospitals which accept surgical emergencies were included in the survey. The information obtained from the case records was recorded on dual-purpose punch-cards to facilitate the subsequent analysis.
The area studied, the technique used, and the criteria adopted are the same as those in the previous surveys by Illingworth et al. (1944) and Jamieson (1955) . The results are therefore comparable.
In this paper I wish to consider four aspects of perforated peptic ulcer: (1) the incidence, (2) the time, (3) the site, and (4) the treatment of perforation. Incidence of Perforation Fig. 1 shows the incidence of perforation in males and females over the 40-year period 1924-63. There was a fairly steady increase, except for the spike occurring in 1940 and 1941, up until the early 1950's. However, over the past 10 years the incidence has declined. There were 5,343 perforations in the period 1954-63, exactly 1,000 fewer than in the previous decade, and this despite a small increase in the popula-
